{
	"root": [
		{
			"id": 0,
			"parent": -1,
			"text": "ROOT",
			"relation": "null",
			"tag": "null"
		},
		{
			"id": 1,
			"parent": 3,
			"text": "Resistance to glucocorticoid therapy has been observed in patients with autoimmune/inflammatory diseases",
			"relation": "BACKGROUND",
			"tag": "Background"
		},
		{
			"id": 2,
			"parent": 1,
			"text": "and may be related to the inflammatory process itself . <S>",
			"relation": "ADDITION",
			"tag": "Background"
		},
		{
			"id": 3,
			"parent": 0,
			"text": "The aim of this study was to examine the ability of tumor necrosis factor alpha ( TNFalpha , a proinflammatory cytokine ) and interleukin ( IL ) -10 ( an anti-inflammatory cytokine ) to differentially regulate the sensitivity of human monocytes/macrophages to glucocorticoids . <S>",
			"relation": "ROOT",
			"tag": "Hypothesis-Objective"
		},
		{
			"id": 4,
			"parent": 5,
			"text": "To accomplish this ,",
			"relation": "ENABLEMENT",
			"tag": "Verification-Method"
		},
		{
			"id": 5,
			"parent": 3,
			"text": "we first analyzed the pattern of TNFalpha and IL-10 inhibition by dexamethasone in LPS-stimulated whole-blood cell cultures . <S>",
			"relation": "VERIFICATION",
			"tag": "Verification-Method"
		},
		{
			"id": 6,
			"parent": 5,
			"text": "Second , we studied the modulation of the sensitivity of these cells to dexamethasone by preincubation with TNFalpha or IL-10 and measurement of LPS-stimulated IL-6 secretion . <S>",
			"relation": "ADDITION",
			"tag": "Verification-Method"
		},
		{
			"id": 7,
			"parent": 5,
			"text": "In addition , we evaluated the effect of dexamethasone on phorbolmyristate-acetate-stimulated IL-1 receptor antagonist secretion by the human monocytic cell line U937 . <S>",
			"relation": "ADDITION",
			"tag": "Verification-Method"
		},
		{
			"id": 8,
			"parent": 5,
			"text": "Finally , we investigated whether the modulation of corticosensitivity in TNFalpha- and IL-10-pretreated U937 cells was related to a change of the glucocorticoid receptor concentration and affinity . <S>",
			"relation": "ADDITION",
			"tag": "Verification-Method"
		},
		{
			"id": 9,
			"parent": 5,
			"text": "Dexamethasone had different effects on LPS-induced TNFalpha and IL-10 secretion ;",
			"relation": "CAUSE-RESULT",
			"tag": "Verification-Result"
		},
		{
			"id": 10,
			"parent": 11,
			"text": "whereas it suppressed TNFalpha in a dose-dependent fashion ,",
			"relation": "COMPARISON",
			"tag": "Verification-Result"
		},
		{
			"id": 11,
			"parent": 9,
			"text": "its effect on IL-10 secretion was biphasic ,",
			"relation": "ELABORATION",
			"tag": "Verification-Result"
		},
		{
			"id": 12,
			"parent": 11,
			"text": "producing stimulation at lower , and inhibition at higher doses . <S>",
			"relation": "ELABORATION",
			"tag": "Verification-Result"
		},
		{
			"id": 13,
			"parent": 9,
			"text": "The concentration of LPS employed influenced the effect of dexamethasone on IL-10 secretion ( P < 0.001 ) . <S>",
			"relation": "ADDITION",
			"tag": "Verification-Result"
		},
		{
			"id": 14,
			"parent": 9,
			"text": "Pretreatment with TNFalpha diminished , and with IL-10 improved , the ability of dexamethasone to suppress IL-6 secretion in whole-blood cell cultures ( P < 0.01 for both ) and to enhance IL-1 receptor antagonist secretion by U937 cells ( P < 0.05 for both ) . <S>",
			"relation": "ADDITION",
			"tag": "Verification-Result"
		},
		{
			"id": 15,
			"parent": 9,
			"text": "TNFalpha decreased ( P < 0.001 ) ,",
			"relation": "ADDITION",
			"tag": "Verification-Result"
		},
		{
			"id": 16,
			"parent": 15,
			"text": "while IL-10 increased ( P < 0.001 ) ,",
			"relation": "COMPARISON",
			"tag": "Verification-Result"
		},
		{
			"id": 17,
			"parent": 15,
			"text": "the concentration of dexamethasone binding sites in these cells , with no discernible effect on their binding affinity . <S>",
			"relation": "SAME-UNIT",
			"tag": "Verification-Result"
		},
		{
			"id": 18,
			"parent": 3,
			"text": "We conclude",
			"relation": "CONCLUSION",
			"tag": "Conclusion"
		},
		{
			"id": 19,
			"parent": 18,
			"text": "that glucocorticoids differentially modulate TNFalpha and IL-10 secretion by human monocytes in a LPS dose-dependent fashion",
			"relation": "ATTRIBUTION",
			"tag": "Conclusion"
		},
		{
			"id": 20,
			"parent": 19,
			"text": "and that the sensitivity of these cells to glucocorticoids is altered by TNFalpha or IL-10 pretreatment ;",
			"relation": "ADDITION",
			"tag": "Conclusion"
		},
		{
			"id": 21,
			"parent": 20,
			"text": "TNFalpha blocks their effects ,",
			"relation": "ELABORATION",
			"tag": "Conclusion"
		},
		{
			"id": 22,
			"parent": 21,
			"text": "whereas IL-10 acts synergistically with glucocorticoids . <S>",
			"relation": "COMPARISON",
			"tag": "Conclusion"
		},
		{
			"id": 23,
			"parent": 18,
			"text": "This is accompanied by opposite glucocorticoid receptor changes , respectively opposing and favoring glucocorticoid actions . <S>",
			"relation": "ELABORATION",
			"tag": "Conclusion"
		},
		{
			"id": 24,
			"parent": 18,
			"text": "This study suggests",
			"relation": "CAUSE-RESULT",
			"tag": "Conclusion"
		},
		{
			"id": 25,
			"parent": 24,
			"text": "that the pattern of pro-/antiinflammatory cytokine secretion may alter the response of patients to glucocorticoid therapy . <S>",
			"relation": "ATTRIBUTION",
			"tag": "Conclusion"
		}
	]
}